KS

Kristi Sarno

Vice President Business Development And Corporate Strategy at Homology Medicines

Kristi Sarno has a diverse work experience spanning various roles in the biopharmaceutical industry. Kristi currently serves as the Vice President of Business Development and Corporate Strategy at Homology Medicines, Inc. since January 2022. Prior to this, they worked as the Senior Director of Business Development and Corporate Strategy at the same company from January 2021 to March 2022.

Before joining Homology Medicines, Inc., Kristi held the position of Senior Director of Business Development at Pfenex Inc from September 2018 to December 2020. Kristi was responsible for leading business development efforts in this role.

From January 2018 to September 2018, Kristi worked as the Director of Strategic Analysis and Commercial Practice at Latham BioPharm Group. During their tenure, they also held the position of Senior Consultant at Latham BioPharm Group, where they provided high-level business development, program management, and strategic consulting services in the life sciences industry.

Prior to joining Latham BioPharm Group, Kristi was the Director of Business Development at Pfenex Inc from November 2012 to August 2015. In this role, they served as the commercial lead for the teriparatide biosimilar program and led a team in analyzing and prioritizing pipeline candidates.

Kristi's earlier work experience includes roles such as Director of Business Development at Laureate Biopharmaceutical Services from May 2011 to November 2012, Associate Director of Business Development at Crucell from October 2009 to May 2011, and Technical Account Manager at Crucell from October 2006 to December 2009.

Kristi began their career as a Research Associate at various institutions, including Acambis, Joslin Diabetes Center, and Beth Israel Deaconess Medical Center.

Overall, Kristi Sarno's work experience showcases their expertise in business development, corporate strategy, and commercial practices in the biopharmaceutical industry.

Kristi Sarno obtained a Bachelor of Science (B.S.) degree in Biology from Syracuse University, where they studied from 1992 to 1996. Following their undergraduate studies, they pursued a Master of Science (M.S.) degree in Virology at Harvard University, completing this program from 2000 to 2003. In addition to their formal education, Kristi Sarno obtained a Project Management Professional (PMP) certification from the Project Management Institute in June 2016.

Links

Previous companies

Latham BioPharm Group logo

Timeline

  • Vice President Business Development And Corporate Strategy

    January, 2022 - present

  • Senior Director Business Development And Corporate Strategy

    January, 2021

View in org chart